First Header Logo Second Header Logo

Connection

Craig Hamilton to Prognosis

This is a "connection" page, showing publications Craig Hamilton has written about Prognosis.
Connection Strength

0.203
  1. Stacey RB, Vera T, Morgan TM, Jordan JH, Whitlock MC, Hall ME, Vasu S, Hamilton C, Kitzman DW, Hundley WG. Asymptomatic myocardial ischemia forecasts adverse events in cardiovascular magnetic resonance dobutamine stress testing of high-risk middle-aged and elderly individuals. J Cardiovasc Magn Reson. 2018 11 22; 20(1):75.
    View in: PubMed
    Score: 0.031
  2. Jordan JH, Vasu S, Morgan TM, D'Agostino RB, Meléndez GC, Hamilton CA, Arai AE, Liu S, Liu CY, Lima JA, Bluemke DA, Burke GL, Hundley WG. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors. Circ Cardiovasc Imaging. 2016 08; 9(8).
    View in: PubMed
    Score: 0.027
  3. Sukpraphrute B, Drafts BC, Rerkpattanapipat P, Morgan TM, Kirkman PM, Ntim WO, Hamilton CA, Cockrum RL, Hundley WG. Prognostic utility of cardiovascular magnetic resonance upright maximal treadmill exercise testing. J Cardiovasc Magn Reson. 2015 Nov 25; 17:103.
    View in: PubMed
    Score: 0.026
  4. Jordan JH, Haag JC, Morgan TM, Vasu S, Stacey B, Hamilton C, Robinson K, Kitzman D, Thohan V, Hundley WG. Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging. J Comput Assist Tomogr. 2014 May-Jun; 38(3):427-33.
    View in: PubMed
    Score: 0.023
  5. Miller CD, Case LD, Little WC, Mahler SA, Burke GL, Harper EN, Lefebvre C, Hiestand B, Hoekstra JW, Hamilton CA, Hundley WG. Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. JACC Cardiovasc Imaging. 2013 Jul; 6(7):785-94.
    View in: PubMed
    Score: 0.021
  6. Charoenpanichkit C, Morgan TM, Hamilton CA, Wallace EL, Robinson K, Ntim WO, Hundley WG. Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing. Circ Cardiovasc Imaging. 2010 Jul; 3(4):392-7.
    View in: PubMed
    Score: 0.017
  7. Walsh TF, Dall'Armellina E, Chughtai H, Morgan TM, Ntim W, Link KM, Hamilton CA, Kitzman DW, Hundley WG. Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress. J Cardiovasc Magn Reson. 2009 Aug 03; 11:25.
    View in: PubMed
    Score: 0.016
  8. Wallace EL, Morgan TM, Walsh TF, Dall'Armellina E, Ntim W, Hamilton CA, Hundley WG. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging. 2009 Mar; 2(3):299-307.
    View in: PubMed
    Score: 0.016
  9. Dall'Armellina E, Morgan TM, Mandapaka S, Ntim W, Carr JJ, Hamilton CA, Hoyle J, Clark H, Clark P, Link KM, Case D, Hundley WG. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol. 2008 Jul 22; 52(4):279-86.
    View in: PubMed
    Score: 0.015
  10. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002 Oct 29; 106(18):2328-33.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.